Grapefruit Drug Interactions a bitter juice to swallow Jeffery D Evans PharmD Assistant Professor of Pharmacy Practice University of Louisiana at Monroe in Shreveport Objectives At the end of this presentation the audience member should be able to ID: 761533
Download Presentation The PPT/PDF document "Grapefruit Drug Interactions: a bitter j..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Grapefruit Drug Interactions:a bitter juice to swallow Jeffery D. Evans. PharmD Assistant Professor of Pharmacy Practice University of Louisiana at Monroe in Shreveport
Objectives At the end of this presentation the audience member should be able to Understand and apply drug – food interactions, specifically grapefruit juice, to patient care Identify commonly prescribed drugs that may have issues if taken with grapefruit juice
Full Disclosure I am from here Grapefruit comes from here
The beginning Felodipine (Plendil) was being studied Concerns arose there was an interaction with ethanol. Single blind trial was setup Placebo group got a non-alcoholic drink ‘Active’ got one shot of vodka However there was a clear difference in taste
The effect Both groups had Several fold higher concentrations of felodipine Significantly lower BP Significantly more adverse effects What could be causing this?
Effects of GFJ on felodipine
Systolic BP variance Wilkinson GR N Engl J Med 2005; 352:2211 - 21
Diastolic BP Variance Wilkinson GR N Engl J Med 2005; 352:2211 - 21
Viagra and Grapefruit juice Viagra + GFJ Viagra + water Jeter A et al. Clinical Pharmacol Ther 2002 Jan; 71(1):21-9
Potential Causes for Drug-Food Interactions Gut transit time Delayed vs accelerated gastric emptying Enzyme manipulation Transporter activity changes
Potential Mechanisms of Action Inactivation of Cyp 3A4 In the gut In the liver Not just inactivation CYP3A4 mRNA decreases after GFJ Possible degradation of the enzyme
Potential Mechanisms of Action P-Glycoprotein (P-gp) A drug transporter Found where 3A4 is Excretes drugs back into the lumen Organic Anion Transfer Protein (OATP) Another drug transporter Not much is known, but data shows GFJ impact
Effects of GFJ on Felodipine
What is to blame for effects? Naringin A flavonoid Not found in other fruit juices In vitro data shows inhibition effects In vivo data does not show effects Quesrcetin Kaempferol X
What is to blame for effects? Furanocoumarins (psoralens) Bergamottin Time dependent Cyp inactivation Concentration dependent Cyp inactivation Others found in GFJ also inactivate CYP
Duration of effect Separating the dose of medication and GFJ prevents effects. No, not really First dose seems to have the same effect as last dose of GFJ Effects seen as far out as seven days
So does it really matter Yes and Maybe 29 year old man Stable with terfenadine 60 mg BID x 1 year Consumed two glasses of GFJ Collapsed and died Had toxic levels of terfenadine Spence et al Clin Pharmacol Ther 61, 395 - 400
Can they help Cyclosporine was a significant expense Undergoes 3A4 metabolism in the gut Transported by P-gp GFJ increased AUC by 60% Allowing for reduction in doses Yee et al Lancet 1995; 345: 955- 956
Resources for GFJ interactions Center for Food-Drug Interaction Research and Education Maintained by the University of Florida Provides information for consumers and HCPs http://www.druginteractioncenter.org/
Significant Interactions with GFJ Amiodarone Buspirone Diazepam Lovastatin Simvastatin
Amiodarone Amiodarone with GFJ increased AUC by 50% Maximum concentration by 84% Trial Single dose Healthy adults Significant amount of GFJ Libersa CC et al J Clin Pharmacol. 49, 373 - 379
Buspirone Buspirone when taken with GFJ AUC increased 9 fold Peak concentration increased 4.3 fold Time to peak concentration was delayed from 0.75 hours to 3 hours Trial Run in phase of three days Double strength GFJ used Lilja et al Clin Pharmacol Ther 1998;64:655-60
Buspirone Lilja et al Clin Pharmacol Ther 1998;64:655-60
Diazepam Use of diazepam and GFJ increased AUC 3.2 fold Maximum concentration 1.5 fold Trial facts Small student Unknown quantities of GFJ Single dose Ozdemir M et al Eur J Drug Metab Pharmacokinet 1998 23(1):55-9
Lovastatin Use of lovastatin and GFJ With 2x strength 12 fold increase in peak concentration 15 fold increase in AUC With 1x strength 1.3 fold increase in peak concentration 1.3 fold increase in AUC Kantola et al Clin Pharmacol Ther 1998; 63:397 – 402 Rogers et al Clin Pharmacol Ther 1999;66:358-66
Simvastatin Use of simvastatin and GFJ With 2x strength GFJ 12 fold increase in peak serum concentration 13.5 fold increase in AUC With 1x strength 3.9 fold increase in peak serum concentration 3.6 fold increase in AUC Lilja et al Clin Pharmacol Ther 2000; 68:384-90 Lilja et al Br J Clin Pharacol 2004 58(1):56- 60
Parting thoughts Drugs to be probably concerned about Atorvastatin 1.4 AUC increase, 1.6 Conc increase Fexofenadine 30% reduction in bioavailability Fukazawa et al Br J Clin Pharmacol 57(4) 448-455 Banfield et al Clin Pharmacokinet 41(4):311- 318